Metastatic poorly differentiated prostatic carcinoma with neuroendocrine differentiation: Negative on 68Ga-PSMA PET/CT

Clinical Nuclear Medicine

Volumn 40, Issue 2, 2015, Pages e163-e166

  Chakraborty, Partha Sarathi ^a   Tripathi, Madhavi ^a   Agarwal, Krishan Kant ^a   Kumar, Rajeev ^a   Vijay, Maneesh Kumar ^a   Bal, Chandrasekhar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

68Ga PSMA; PET CT; prostate cancer; skeletal scintigraphy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PSMA GA 68; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; EDETIC ACID; GLU-NH-CO-NH-LYS-(AHX)-((68)GA(HBED-CC)); OLIGOPEPTIDE;

ADULT; ARTICLE; BONE SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; MALE; NEUROENDOCRINE TUMOR; PROSTATE CARCINOMA; ANALOGS AND DERIVATIVES; CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR; SCINTISCANNING;

ADULT; CARCINOMA; EDETIC ACID; HUMANS; MALE; MULTIMODAL IMAGING; NEUROENDOCRINE TUMORS; OLIGOPEPTIDES; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84921609126     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000594     Document Type: Article

References (8)

1. Moul JW. Population screening for prostate cancer and emerging concepts for young men. Clin Prostate Cancer. 2003;2:87-97
2. Johnson DE, Lanieri JP Jr, Ayala AG. Prostatic adenocarcinoma occurring in men under 50 years of age. J Surg Oncol. 1972;4:207-216
3. Lugnani F, Simone G, Biava PM, et al. The role of neuroendocrine cells in prostate cancer: a comprehensive review of current literature and subsequent rationale to broaden and integrate current treatment modalities. Curr Med Chem. 2014;21: 1082-1092
4. Sweat SD, Pacelli A, Murphy GP, et al. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology. 1998;52:637-640
5. Mannweiler S, Amersdorfer P, Trajanoski S, et al. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol Oncol Res. 2009;15:167-172
6. Afshar-Oromeih A, Malcher A, Eder M, et al. PET imaging with a [ Ga] gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumor lesions. Eur J Nucl Med Mol Imaging. 2013;40:486-495
7. Afshar-Oromeih A, Haberkorn U, Eder M, et al. [ Ga]Gallium-labelled PSMA ligand as superior PET tracer for diagnosis of prostate cancer: comparison with F-FECH. Eur J Nucl Med Mol Imaging. 2012;39:1085-1086
8. Abrahamsson PA, Falkmer S, Falt K, et al. The course of neuroendocrine differen tiation in prostate carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker." Pathol Res Pract. 1989;185:373-380